Clinical Trial

Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients

Study acronym: MOMENT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the efficacy of modulated mid-frequency whole-body electromyostimulation (WB-EMS) combined with nutritional therapy in patients with gastrointestinal cancer.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-09 -> 2028-08 2026-07-28
minor Completion pushed: 2026-09 -> 2028-08 2026-07-28
Trial Details
NCT Number NCT06414122
Lead Sponsor University of Cologne
Conditions Oesophageal Cancer, Gastric Cancer, Duodenal Cancer, Colorectal Cancer
Enrollment 88 participants
Start Date 2026-08-01
Primary Completion 2028-08 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-27